Behavior of AV synchrony pacing mode in a leadless pacemaker during variable AV conduction and arrhythmias.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
07 2021
Historique:
revised: 03 03 2021
received: 18 11 2020
accepted: 16 03 2021
pubmed: 1 5 2021
medline: 11 8 2021
entrez: 30 4 2021
Statut: ppublish

Résumé

MARVEL 2 assessed the efficacy of mechanical atrial sensing by a ventricular leadless pacemaker, enabling a VDD pacing mode. The behavior of the enhanced MARVEL 2 algorithm during variable atrio-ventricular conduction (AVC) and/or arrhythmias has not been characterized and is the focus of this study. Of the 75 patients enrolled in the MARVEL 2 study, 73 had a rhythm assessment and were included in the analysis. The enhanced MARVEL 2 algorithm included a mode-switching algorithm that automatically switches between VDD and ventricular only antibradycardia pacing (VVI)-40 depending upon AVC status. Forty-two patients (58%) had persistent third degree AV block (AVB), 18 (25%) had 1:1 AVC, 5 (7%) had variable AVC status, and 8 (11%) had atrial arrhythmias. Among the 42 patients with persistent third degree AVB, the median ventricular pacing (VP) percentage was 99.9% compared to 0.2% among those with 1:1 AVC. As AVC status changed, the algorithm switched to VDD when the ventricular rate dropped less than 40 bpm. During atrial fibrillation (AF) with ventricular response greater than 40 bpm, VVI-40 mode was maintained. No pauses longer than 1500 ms were observed. Frequent ventricular premature beats reduced the percentage of AV synchrony. During AF, the atrial signal was of low amplitude and there was infrequent sensing. The mode switching algorithm reduced VP in patients with 1:1 AVC and appropriately switched to VDD during AV block. No pacing safety issues were observed during arrhythmias.

Identifiants

pubmed: 33928713
doi: 10.1111/jce.15061
pmc: PMC8360010
doi:

Banques de données

ClinicalTrials.gov
['NCT03752151']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1947-1957

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 The Authors. Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC.

Références

Curr Cardiol Rep. 2015 Aug;17(8):68
pubmed: 26233700
JACC Clin Electrophysiol. 2020 Jan;6(1):94-106
pubmed: 31709982
J Am Coll Cardiol. 2012 Oct 16;60(16):1540-5
pubmed: 22999727
Europace. 2013 Aug;15(8):1070-118
pubmed: 23801827
Europace. 2002 Apr;4(2):137-41
pubmed: 12135244
Circulation. 1978 Aug;58(2):314-21
pubmed: 668080
J Interv Card Electrophysiol. 1998 Jun;2(2):175-9
pubmed: 9870010
J Cardiovasc Electrophysiol. 2021 Jul;32(7):1947-1957
pubmed: 33928713
J Am Coll Cardiol. 2007 Aug 14;50(7):614-22
pubmed: 17692746
Am J Cardiol. 2003 Sep 15;92(6):740-1
pubmed: 12972124
Heart. 1999 Jun;81(6):580-5
pubmed: 10336914
Heart Rhythm. 2018 Dec;15(12):1800-1807
pubmed: 30103071
Int J Cardiol. 2015 Apr 15;185:95-100
pubmed: 25804349
Circulation. 2003 Jun 17;107(23):2932-7
pubmed: 12782566
Heart Rhythm. 2018 Mar;15(3):376-383
pubmed: 29122724
Pacing Clin Electrophysiol. 2019 Mar;42(3):381-387
pubmed: 30687931

Auteurs

Christophe Garweg (C)

Department of Cardiovascular Sciences, University Hospitals Leuven, University of Leuven, Leuven, Belgium.

Surinder Kaur Khelae (SK)

Department of Electrophysiology, Institut Jantung Negara, Kuala Lumpur, Malaysia.

Joseph Yat Sun Chan (JYS)

Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong.

Larry Chinitz (L)

Leon H. Charney Division of Cardiology, NYU Langone Medical Center, New York, New York, USA.

Philippe Ritter (P)

Department of Electrophysiology and Cardiac Stimulation, Hôpital Haut- Lévêque-CHU de Bordeaux, Pessac, France.

Jens Brock Johansen (JB)

Department of Cardiology, Odense University Hospital, Odense, Denmark.

Venkata Sagi (V)

Baptist Heart Specialists, Baptist Medical Center, Jacksonville, Florida, USA.

Laurence M Epstein (LM)

Department of Electrophysiology, North Shore University Hospital, Manhasset, New York, USA.

Jonathan P Piccini (JP)

Division of Cardiology, Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina, USA.

Mario Pascual (M)

Miami Cardiac & Vascular Institute, Baptist Hospital, Miami, Florida, USA.

Lluis Mont (L)

Institut Clinic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain.

Rik Willems (R)

Department of Cardiovascular Sciences, University Hospitals Leuven, University of Leuven, Leuven, Belgium.

Vincent Splett (V)

Medtronic, Inc., Minneapolis, Minnesota, USA.

Kurt Stromberg (K)

Medtronic, Inc., Minneapolis, Minnesota, USA.

Todd Sheldon (T)

Medtronic, Inc., Minneapolis, Minnesota, USA.

Nina Kristiansen (N)

Medtronic Bakken Research Center, Maastricht, The Netherlands.

Clemens Steinwender (C)

Department of Cardiology, Kepler University Hospital, Medical Faculty, Johannes Kepler University, Linz, Austria.
Department of Cardiology, Paracelsus Medical University Salzburg, Salzburg, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH